Nicola J. Mason

Veterinary <scp>Cooperative</scp> Oncology Group—Common Terminology Criteria for Adverse Events (<scp>VCOG‐CTCAE</scp> v2) following investigational therapy in dogs and cats

Amy K. LeBlanc, Matthew J. Atherton, R. Timothy Bentley et al. · Veterinary and Comparative Oncology · 2021 · 296 citations · Full text

Pathology, Veterinary Research, Investigational Therapy +18

Critical roles of c-Rel in autoimmune inflammation and helper T cell differentiation

Brendan Hilliard, Nicola J. Mason, Lingyun Xu et al. · Journal of Clinical Investigation · 2002 · 203 citations · Full text

Critical roles of c-Rel in autoimmune inflammation and helper T cell differentiation

Brendan Hilliard, Nicola J. Mason, Lingyun Xu et al. · Journal of Clinical Investigation · 2002 · 178 citations

Autoimmune Inflammation, Th2 Cell Differentiation, Lymphocyte Development +27

Checkpoint Blockade Reverses Anergy in IL-13Rα2 Humanized scFv-Based CAR T Cells to Treat Murine and Canine Gliomas

Yibo Yin, Alina C. Boesteanu, Zev A. Binder et al. · Molecular Therapy — Oncolytics · 2018 · 175 citations · Full text

Immunotherapy with a HER2-Targeting <i>Listeria</i> Induces HER2-Specific Immunity and Demonstrates Potential Therapeutic Effects in a Phase I Trial in Canine Osteosarcoma

Nicola J. Mason, Josephine S. Gnanandarajah, Julie B. Engiles et al. · Clinical Cancer Research · 2016 · 170 citations